AI-based video system may offer quick, no-contact screenings for high blood pressure and diabetes

A new system that combines high-speed video and an artificial intelligence (AI)-powered algorithm may offer quick, no-contact screenings for high blood pressure and Type 1 or Type 2 diabetes without needing blood tests, blood pressure cuffs or expensive wearable devices, according to a preliminary study to be presented at the American Heart Association’s Scientific Sessions 2024.

Navigating market access in Sweden – Pharmaceutical Technology

Stockholm, Sweden. Demand for pharmaceuticals is growing in Sweden and healthcare expenditure is increasing, with GlobalData expecting 2.9% growth in 2023 and a 4.4% rise

August 8, 2023

Artificial Hips Snapped in Half; Obesity Drug Windfall for Docs; Clinicians Unionize

Welcome to the latest edition of Investigative Roundup, highlighting some of the best investigative reporting on healthcare each week. Artificial Hips Snapped in Half More

December 7, 2023

Exelixis cuts 175 staffers to prioritize late-stage drug development

Exelixis is laying off 175 employees, or 13% of its workforce, to “rebalance resources” with a focus on candidates closer to market. The company appears

January 9, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.